This Valentine’s Day, let’s take a moment to talk about Heart health. ❤️ ️

15 February, 2023

Did you know that heart disease is the leading cause of death worldwide, accounting for more deaths than all types of cancer combined? The impact it has on our society and healthcare system is staggering, with costs in the US alone reaching over $230 billion per year.

Read more

Stimulating Production and Extraction of Metabolites in Plants

14 February, 2023

It's no secret that plants carry unique properties, for centuries plants have been used for a range of applications, including food, drugs and cosmetics.

But did you know that the benefits of plants can now be used without any interference to the plant itself?

The team led by Professor. Asaph Aharoni, from the Weizmann Institute of Science, has developed a method of inducing metabolite production in plants and extracting them without any harm being done.

Discover how in our latest newsletter:

 

Read more

Revolutionary discovery places Xinteza at the forefront of cannabinoid sourcing

07 February, 2023

Innovative biosynthesis technology company, Xinteza API, recently made a breakthrough discovery of a novel, non-cannabis plant-derived production system, capable of highly efficient and flawless end-to-end cannabinoid synthesis. This discovery is a major milestone in the path to uncover and exploit rare and new cannabinoid molecules with potentially novel pharmacological activities.

Xinteza is a spinoff company of Yeda, while leading the research is Professor Asaph Aharoni from the Weizmann Institute of Science.

Read more

Meet Prof. Adi Kimchi, a principal investigator at the Molecular Genetics department.

05 February, 2023

The Kimchi Lab studies programmed cell death (PCD), an intricate molecular network governing a cell's decision to live or die. The lab aims to uncover new PCD targets and ultimately identify points of vulnerability in human disease amenable to therapeutic intervention.

Discover more about the research being done at the Kimchi Lab in our newsletter:

Read more

Protein comes in many shapes and forms, from meat and dairy to beans and bugs!

30 January, 2023

Yes, you read that correctly, bugs.

With the world facing an unprecedented food crisis, the food-tech space has taken an interest in using bugs as an alternative source of protein. Bugs not only offer high nutritional value, they also produce fewer greenhouse gasses, emit less ammonia than farm animals and take up less space, water, and land than traditional sources of protein.

Read more

The race to build the next generation of computers is on!

30 January, 2023

Israel's leading #QuantumComputing experts recently spoke in a panel during Calcalist כלכליסט Innovation Week. Amongst the speakers were Gil Semo from Quantum Source Labs Ltd and Dr. Ruti Ben Shlomi from LightSolver, two notable spinoffs of Yeda.

Learn more about the future of quantum computing:

Read more

Decentralized low-cost emissions-free ammonia via electro catalytic reaction of water and air.

24 January, 2023

Decentralized low-cost emissions-free ammonia via electro catalytic reaction of water and air.

NitroFix, a spinoff company of Yeda, brings in a stable and scalable catalyst to an electrochemical process that can take place at room temperature, no heat and pressure needed.

Nitrofix allows on-site generation of ammonia for fertilizers and emerging use cases in fossil-free maritime fuels. Emissions-free ammonia is essential to decarbonize this legacy industry that burns 3% of the world’s natural gas.

 

Read more

Yeda's Newsletter - Jan 2022

23 January, 2022

The first edition of our newsletter is dedicated to some of our key highlights in 2021. The past year was a record year for licensing agreements. In addition, many potential deals were added to our pipeline, and we look forward to seeing many of them materialize in 2022.

Read more

Did you know that the mortality rate in acute myeloid leukemia (AML) is 90% when diagnosed after the age of 65?

19 January, 2023

With no preventative therapy currently available for pre-leukemic individuals, that number is alarming. However, a group led by Professor Liran Shlush at the Weizmann Institute of Science has found that treatment with ROCK inhibitors can inhibit the growth of pre-leukemic mutated cells. This in turn, prevents disease onset.

This breakthrough could ultimately change the course of AML.

Discover more in our latest newsletter:

Read more

IndieBio San Francisco - Batch 13 Demo Day is taking place tomorrow (January 19).

19 January, 2023

IndieBio San Francisco - Batch 13 Demo Day is taking place tomorrow (January 19).

Join some of the top curated startups in climate tech, biotech and deep tech, including Yeda spinoff company NitroFix.

NitroFix was established based on research done at the laboratory of Professor Ronny Neumann from the Faculty of Chemistry at the Weizmann Institute of Science. It is the world's first proprietary electrolyzer that produces green ammonia directly from nitrogen and water, without the need for hydrogen.

Interested in learning more? Register online for free:

 

Read more

Pages

Subscribe to YEDA Technology Transfer RSS